Average daily dose of guideline-recommended treatments prescribed around the time of incident heart failure in patients diagnosed from 2012–2014.
figure
posted on 2019-05-21, 17:23 authored by Nathalie Conrad, Andrew Judge, Dexter Canoy, Jenny Tran, Johanna O’Donnell, Milad Nazarzadeh, Gholamreza Salimi-Khorshidi, F. D. Richard Hobbs, John G. Cleland, John J. V. McMurray, Kazem RahimiAverage daily dose prescribed to patients with heart failure and reduced ejection fraction without drug-specific contraindications or intolerances, from 3 months prior up to 12 months following incident heart failure, in patients diagnosed between 2012 and 2014, smoothed with local polynomial regression. Average daily dose is expressed as a percentage of the guideline-recommended target dose. ACE-I, angiotensin-converting–enzyme inhibitor; ARB, angiotensin receptor blocker; MRA, mineralocorticoid receptor antagonist.
History
Usage metrics
Keywords
RRangiotensin receptor blockersincident heart failureheart failure patientsejection fraction valuesretrospective population-based studyheart failureCPRDUKQuality improvement effortsevidence-based heart failure managementCIPrimary care referraldrug treatment dosecommunity heart failure clinicsClinical Practice Research DatalinkdiagnosisACE-Icategory-specific risk ratiosARBbeta blockers
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC